Register Now
Why register?
 The leading web portal for pharmacy resources, news, education and careers April 19, 2019
Pharmacy Choice - Nutrition 21 - April 19, 2019

Nutrition 21

Nutrition 21 Logo Nutrition 21 is pioneering an effort to use patented technology, pharmaceutical research and strategic marketing and distribution partnerships to build its position in therapeutic markets. The Company is targeting the diabetes marketplace and related health markets where poor insulin function is a metabolic risk factor. These include obesity, metabolic syndrome, cardiovascular disease and depression.

Poor insulin function and glucose control are strong bio-markers for diabetes. Chromium is a trace mineral essential for healthy insulin function and blood sugar levels. The Company holds 24 U.S. patents for chromium compounds, their uses and Chromax® chromium picolinate, a unique form of chromium with superior bioactivity. Twelve (12) published clinical studies involving over 1500 subjects demonstrate that supplemental use of Chromax chromium picolinate, at 200 to 1000 mcg has demonstrated an ability to improve glycemic control in people with or at risk for diabetes.

The patented findings and recent discoveries, including insights into chromium picolinate’s mechanism of action and the detection of a strong correlation between low chromium status and the incidence of cardiovascular disease and diabetes are generating significant excitement among metabolic researchers. The health benefits of Chromax use have also been observed in people with high cholesterol, in obese populations and in people suffering with atypical depression. In addition, women’s reproductive health is a new area of scientific interest for chromium picolinate researchers.

Healthcare providers are most likely to rely on FDA approved drugs as the first course of therapy for patients, particularly those suffering with high-risk chronic diseases. Therefore, Nutrition 21 relies on large-scale double-blind placebo-controlled clinical trials as a key element of its marketing strategy. The company’s objective is to translate its scientific findings into trusted brands recognized for their measurable contribution to improving public health and reducing cost of care. The Company’s plan is to not only earn the trust of consumers, but to secure an endorsement from healthcare professionals with the ultimate objective of getting its products adopted as a standard treatment for diabetes management.

Different from most biotechnology or pharmaceutical companies, the Company is focused on developing products that are marketed under the Dietary Supplement Health and Education Act (DSHEA) regulatory pathway. The Food and Drug Administration’s (FDA) regulations for the supplement category enable companies to bring products to market in less time and with less cost than is required for FDA drug approval. In order to establish credibility among healthcare experts, the company is seeking an FDA qualified health claim acknowledging the health benefit of its products in reducing the risk of diabetes and conditions associated with insulin resistance.

Armed with clinical evidence that promises to reveal remarkable, clinically measurable effects of its products in therapeutic approaches to epidemic diseases like diabetes, obesity and depression, Nutrition 21 enjoys the following unique competitive advantages:
  • An established base business that supports a robust clinical research and business development effort;
  • An expertise in identifying and patenting nutrition therapies addressing overlapping health markets that affect as many as 25 percent of US adults;
  • A history of successfully patenting its innovations and enforcing its patents;
  • Research alliances with leading universities, research institutes and scientists; and
  • A proven track record in leveraging clinical outcomes to build consumer and trade awareness for its nutrition products through public relations.
Nutrition 21 is fully committed to the responsible marketing of dietary supplements. The company not only uses pharmaceutical research standards to establish the safety and efficacy of the products it markets, but also maintains that commitment through a rigorous quality assurance program. Good science is the Nutrition 21 hallmark that distinguishes the Company as a pioneer and a leader in the nutrition industry.

Websites »
Copyright © 2019 Pharmacy Choice - All rights reserved.
Terms and Conditions | Privacy Statement